phase 1
b 1
study 1
mammalian 1
target 1
rapamycin 1
inhibitor 1
sirolimus 1
combination 1
nanoparticle 1
albuminbound 1
paclitaxel 1
patients 1
advanced 1
solid 1
tumors 1
